前列腺穿刺活检的适应证、使用情况及并发症:纽约州分析
利用纽约州SPARCS数据库分析2011至2014年前列腺穿刺活检的使用趋势与并发症。门诊活检使用随时间下降(p<0.01),感染率从2.6%升至3.5%(p=0.02)。多因素分析显示糖尿病、经直肠途径和近期住院与感染显著相关。
要点
- 门诊前列腺穿刺活检使用随时间下降(p<0.01)。
- 活检相关感染率从2.6%升至3.5%(p=0.02)。
- 经直肠途径感染风险高于经会阴(OR 3.48,95%CI 1.27-9.54,p=0.02)。
核心结论
- 纽约州前列腺穿刺活检后感染性并发症随时间增加;经直肠途径并发症较高且靶向抗生素预防使用极少,作者认为应进一步努力评估和实施这些策略以减少全国前列腺穿刺活检后并发症。
研究设计与样本
- 利用SPARCS(纽约州规划与研究合作系统)识别2011至2014年经直肠和经会阴途径的前列腺穿刺活检(分别为9,472例和421例患者)。
- 使用泊松回归和Cochrane-Armitage检验分析使用趋势和并发症,应用逻辑回归检查活检后30天内并发症的预测因素。
主要发现
- 门诊前列腺穿刺活检使用随时间下降(p<0.01)。
- 前列腺穿刺活检最常见适应证为前列腺特异性抗原升高(53.2%),其次为癌症主动监测(26.7%)、直肠指检异常(2.6%)和不典型增生(1.6%)。
- 研究期间活检相关感染率从2.6%升至3.5%(p=0.02)。
- 777例重复前列腺穿刺活检的并发症率与初次活检相当;术前直肠拭子采集在不到1%的活检中进行。
- 多因素分析中,患者种族、手术年份、糖尿病(OR 1.92,95%CI 1.29-2.86,p<0.01)、经直肠途径(OR 3.48,95%CI 1.27-9.54,p=0.02)和近期住院(OR 2.03,95%CI 1.43-2.89,p<0.01)与感染显著相关;感染性并发症的中位总费用为$4,129(IQR 711-19,185)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Uptake of active surveillance and changes in prostate cancer care may affect the utilization of and complications following prostate needle biopsy. We characterized recent trends and risk factors for prostate needle biopsy complications using a statewide, all-payer cohort. MATERIALS AND METHODS: We used SPARCS (New York Statewide Planning and Research Cooperative System) to identify prostate needle biopsies performed between 2011 and 2014 via the transrectal and the transperineal approach (9,472 and 421 patients, respectively). We characterized trends in utilization and complications using Poisson regression and the Cochrane-Armitage test. We applied logistic regression to examine predictors of complications within 30 days of prostate needle biopsy. RESULTS: Ambulatory use of prostate needle biopsy decreased with time (p <0.01). The most common indication for prostate needle biopsy was elevated prostate specific antigen in 53.2% of patients, followed by active surveillance for cancer in 26.7%, abnormal digital rectal examination in 2.6% and atypia in 1.6%. The prostate needle biopsy associated infection rate increased from 2.6% to 3.5% during the study period (p = 0.02). Among the 777 repeat prostate needle biopsies, the complication rate was comparable to that of initial prostate needle biopsy. Preprocedural rectal swab was done in less than 1% of prostate needle biopsies. On multivariable analysis, patient race, procedure year, diabetes (OR 1.92, 95% CI 1.29-2.86, p <0.01), transrectal approach (OR 3.48, 95% CI 1.27-9.54, p = 0.02) and recent hospitalization (OR 2.03, 95% CI 1.43-2.89, p <0.01) were significantly associated with infection. The median total charge for infectious complications was $4,129 (IQR 711-19,185). CONCLUSIONS: Across New York State, infectious complications after prostate needle biopsy have increased over time. With higher complications using the transrectal approach and minimal utilization of targeted antibiotic prophylaxis, further efforts should focus on the evaluation and implementation of these strategies to reduce post-prostate needle biopsy complications nationally.
引用
- Halpern JA, Sedrakyan A, Dinerman B, et al. Indications, Utilization and Complications Following Prostate Biopsy: New York State Analysis. J Urol. 2016. PMID: 27856226. doi:10.1016/j.juro.2016.11.081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。